Immunotherapy includes strategies to enhance immune cell activation in patients to better target cancers, as well as cell-based therapies where patients receive genetically modified immune cells targeting cancer cells. Our main strategy is to increase the presence of active lymphocytes in the tumors by boosting the activity of  T-cells and NK-cells within the tumor microenvironment.